Literature DB >> 14564412

A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy.

Satu Kärkkäinen1, Raija Miettinen, Petri Tuomainen, Päivi Kärkkäinen, Tiina Heliö, Eeva Reissell, Maija Kaartinen, Lauri Toivonen, Markku S Nieminen, Johanna Kuusisto, Markku Laakso, Keijo Peuhkurinen.   

Abstract

Approximately 20-35% of cases of idiopathic dilated cardiomyopathy are familial. DCM-associated mutations have been reported in 13 genes including the desmin, delta-sarcoglycan, and metavinculin genes. This study screened for variants in these genes in Finnish patients with DCM. All coding regions of the desmin and delta-sarcoglycan genes and the metavinculin-specific exon of the vinculin gene were screened in 52 DCM patients from eastern Finland by PCR-SSCP. We detected a novel mutation, Arg71Thr, in the delta-sarcoglycan gene in two members of a small DCM family. One of the mutation carriers fulfills diagnostic criteria for DCM and is also symptomatic. The other mutation carrier has slightly dilated left ventricle and well preserved systolic function. Therefore carriers of the Arg71Thr mutation had a relatively mild phenotype and a late onset of the disease. Disease-associated mutations were not found in the desmin gene or the metavinculin-specific exon of the vinculin gene. We conclude that the desmin and delta-sarcoglycan genes are not predominant disease-causing genes in patients with DCM in eastern Finland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564412     DOI: 10.1007/s00109-003-0480-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  41 in total

1.  Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy.

Authors:  T M Olson; N Y Kishimoto; F G Whitby; V V Michels
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function.

Authors:  D J Milner; G E Taffet; X Wang; T Pham; T Tamura; C Hartley; A M Gerdes; Y Capetanaki
Journal:  J Mol Cell Cardiol       Date:  1999-11       Impact factor: 5.000

3.  Metavinculin mutations alter actin interaction in dilated cardiomyopathy.

Authors:  Timothy M Olson; Susanne Illenberger; Nina Y Kishimoto; Stefan Huttelmaier; Mark T Keating; Brigitte M Jockusch
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

4.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

5.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.

Authors:  T M Olson; V V Michels; S N Thibodeau; Y S Tai; M T Keating
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

Review 6.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

Authors:  L Mestroni; B Maisch; W J McKenna; K Schwartz; P Charron; C Rocco; F Tesson; A Richter; A Wilke; M Komajda
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

7.  No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.

Authors:  Satu Kärkkäinen; Keijo Peuhkurinen; Pertti Jääskeläinen; Raija Miettinen; Päivi Kärkkäinen; Johanna Kuusisto; Markku Laakso
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

8.  Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy.

Authors:  K Yoshida; A Nakamura; M Yazaki; S Ikeda; S Takeda
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

9.  Missense mutations in desmin associated with familial cardiac and skeletal myopathy.

Authors:  L G Goldfarb; K Y Park; L Cervenáková; S Gorokhova; H S Lee; O Vasconcelos; J W Nagle; C Semino-Mora; K Sivakumar; M C Dalakas
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  A novel X-linked gene, G4.5. is responsible for Barth syndrome.

Authors:  S Bione; P D'Adamo; E Maestrini; A K Gedeon; P A Bolhuis; D Toniolo
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more
  12 in total

1.  Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy.

Authors:  Ida Luisa Rotundo; Stefania Faraso; Elvira De Leonibus; Gerardo Nigro; Carmen Vitiello; Alessio Lancioni; Daniele Di Napoli; Sigismondo Castaldo; Vincenzo Russo; Fabio Russo; Giulio Piluso; Alberto Auricchio; Vincenzo Nigro
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

Review 2.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 3.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

Review 4.  Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

Authors:  Ray E Hershberger; Dale J Hedges; Ana Morales
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

5.  Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.

Authors:  Matthew D Campbell; Marc Witcher; Anoop Gopal; Daniel E Michele
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-11       Impact factor: 4.733

6.  S151A δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice.

Authors:  Désirée Rutschow; Ralf Bauer; Caroline Göhringer; Raffi Bekeredjian; Stefanie Schinkel; Volker Straub; Michael Koenen; Dieter Weichenhan; Hugo A Katus; Oliver J Müller
Journal:  Eur J Hum Genet       Date:  2013-05-22       Impact factor: 4.246

7.  Does delta-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?

Authors:  Ralf Bauer; Judith Hudson; Harald D Müller; Clemens Sommer; Gabriele Dekomien; John Bourke; Daniel Routledge; Kate Bushby; Jörg Klepper; Volker Straub
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

8.  A novel custom resequencing array for dilated cardiomyopathy.

Authors:  Rebekah S Zimmerman; Stephanie Cox; Neal K Lakdawala; Allison Cirino; Debora Mancini-DiNardo; Eugene Clark; Annette Leon; Elizabeth Duffy; Emily White; Samantha Baxter; Manal Alaamery; Lisa Farwell; Scott Weiss; Christine E Seidman; Jonathan G Seidman; Carolyn Y Ho; Heidi L Rehm; Birgit H Funke
Journal:  Genet Med       Date:  2010-05       Impact factor: 8.822

9.  Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.

Authors:  Ray E Hershberger; Ana Morales; Jill D Siegfried
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

10.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.